Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle
- 1 January 2009
- journal article
- Published by Elsevier BV in Veterinary Microbiology
- Vol. 133 (1-2), 1-8
- https://doi.org/10.1016/j.vetmic.2008.05.032
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheepVaccine, 2007
- Differentiation between field and vaccine strain of bluetongue virus serotype 16Veterinary Microbiology, 2006
- Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central ItalyPreventive Veterinary Medicine, 2005
- Bluetongue Virus in the Mediterranean Basin 1998–2001The Veterinary Journal, 2002
- Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigensVeterinary Immunology and Immunopathology, 1997
- Vaccines for bluetongueAustralian Veterinary Journal, 1996
- The effects of vaccination of Merino ewes with an attenuated Australian bluetongue virus serotype 23 at different stages of gestationAustralian Veterinary Journal, 1995
- Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protectionVaccine, 1994
- The epidemiology of bluetongueComparative Immunology, Microbiology and Infectious Diseases, 1994
- Protective efficacy of virus-like particles for bluetongue diseaseVaccine, 1992